{"id":"W2049816046","doi":"10.1097/00002826-200201000-00005","title":"A Double-Blind Crossover, Placebo-Controlled Study of the Adenosine A2A Antagonist Theophylline in Parkinson's Disease","year":2002,"lang":"en","type":"article","venue":"Clinical Neuropharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Theophylline; Crossover study; Antagonist; Placebo; Medicine; Adenosine; Double blind; Anesthesia; Pharmacology; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002374088,0.001691694,0.004523976,0.000704304,0.0008572245,0.0007771027,0.0008479918,0.00221386,0.003886844],"category_scores_gemma":[0.002645954,0.0007382921,0.0009544538,0.0005783433,0.001996035,0.001173844,0.0004107033,0.002147122,0.0007526496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004425293,"about_ca_system_score_gemma":0.0009556026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005266831,"about_ca_topic_score_gemma":0.0007968302,"domain_scores_codex":[0.9987141,0.0005585587,0.0001509951,0.000295423,0.0001183619,0.000162655],"domain_scores_gemma":[0.9984017,0.0005446283,0.0002577709,0.0001495867,0.0001333349,0.0005129496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9431593,0.0266192,0.0006794633,0.0005935609,0.0004904961,0.00004838383,0.0001220656,0.0001484197,0.01064158,0.00009068612,0.00042002,0.01698669],"study_design_scores_gemma":[0.7153955,0.2780758,0.003973602,0.00002109974,0.0002425452,0.00003480332,0.00002700331,0.0002795045,0.001133609,0.000100695,0.0006962843,0.00001950473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874527,0.003580391,0.0011397,0.000316207,0.0008143074,0.004676462,0.0005760886,0.0001668044,0.001277287],"genre_scores_gemma":[0.9844227,0.00214623,0.002849854,0.0007847801,0.0008837373,0.005770242,0.000674435,0.00003168088,0.002436237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004523976,"threshold_uncertainty_score":0.01300281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05653257955031033,"score_gpt":0.3572882097378645,"score_spread":0.3007556301875541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}